TITLE

Neonatal screening for cystic fibrosis

AUTHOR(S)
Phelan, P D
PUB. DATE
July 1995
SOURCE
Thorax;Jul1995, Vol. 50 Issue 7, p705
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66075345

 

Related Articles

  • Implementation of cystic fibrosis services in developing countries: Memorandum from a joint...  // Bulletin of the World Health Organization;1997, Vol. 75 Issue 1, p1 

    Defines strategies for the implementation and development of cystic fibrosis services. Problems in countries where cystic fibrosis is common; Determination of the incidence of cystic fibrosis in infants; Purposes of neonatal screening projects; Importance of the development of diagnosis and...

  • Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. Rameri, Enzo; Ryall, Richard G.; Morris, C. Phillip; Nelson, Paul V.; Carey, William F.; Pollard, Anthony C.; Robertson, Evelyn F. // BMJ: British Medical Journal (International Edition);5/25/91, Vol. 302 Issue 6787, p1237 

    Assesses the effectiveness of neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. Estimation of immunoreactive trypsinogen; Use of direct gene analysis; Advantages of neonatal screening and diagnosis of cystic fibrosis.

  • Call for routine cystic fibrosis screening. Kmietowicz, Zosia // BMJ: British Medical Journal (International Edition);10/11/97, Vol. 315 Issue 7113, p901 

    Focuses on a study published in a 1997 issue of `New England Journal of Medicine,' on the benefits of neonatal screening for cystic fibrosis in the United States. Background on the study; Early diagnosis of cystic fibrosis among newborns; Lessons for British health care specialists; Areas in...

  • Neonatal screening for cystic fibrosis in the Oxford genetics Laboratory: A review of the first year of testing.  // Journal of Medical Genetics;Sep2007 Supplement 1, Vol. 44, pS95 

    An abstract of the study "Neonatal screening for cystic fibrosis in the Oxford genetics Laboratory: A review of the first year of testing" is presented.

  • Long-term heath outcomes of neonatal screening for cystic fibrosis. Festini, F.; Taccetti, G.; Galici, V.; Campana, S.; Mergni, G.; Repetto, T. // Archives of Disease in Childhood;Apr2008, Vol. 93 Issue 4, p357 

    A letter to the editor is presented in response to the topic concerning long-term health outcomes of neonatal screening for cystic fibrosis.

  • Neonatal screening for cystic fibrosis. Wald, Nicholas J.; Morris, Joan K. // BMJ: British Medical Journal (International Edition);02/07/98, Vol. 316 Issue 7129, p404 

    Editorial. Discusses the possible benefits of neonatal screening in the treatment of cystic fibrosis in children. Procedures used for neonatal screening tests; Result of the study conducted in neonates about the benefit of screening.

  • Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience. Ranieri, Enzo; Lewis, Bary D.; Gerace, Rosemarie L.; Ryall, Richard G.; Morris, C. Phillip; Nelson, Paul V.; Carey, William F.; Robertson, Evelyn F. // BMJ: British Medical Journal (International Edition);6/4/94, Vol. 308 Issue 6942, p1469 

    Assesses the impacts of neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis in Australia. Measurement of the immunoreactive trypsinogen of the first tier neonatal screening; Direct gene analysis of the cystic fibrosis mutations; Examination of the...

  • Sweat testing in newborns positive to neonatal screening for cystic fibrosis. Taccetti, G.; Festini, F.; Braccini, G.; Campana, S.; De Martino, M. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2004, Vol. 89 Issue 5, pF463 

    Sweat chloride concentrations above 40 mmol/l are unusual in newborns screened for cystic fibrosis and should be followed up. Centiles of sweat chloride concentrations in newborns positive to cystic fibrosis neonatal screening are presented. There are not significant correlations between age at...

  • False negative newborn screen and neonatal cholestasis in a premature child with cystic fibrosis. Heidendael, J.; Tabbers, M.; Vreede, I. // European Journal of Pediatrics;Dec2014, Vol. 173 Issue 12, p1581 

    Newborn screening for cystic fibrosis enables early diagnosis and treatment, leading to better outcomes for patients with cystic fibrosis. Although the sensitivity of several screening protocols is high, false negative screening results of the newborn patient still occur, which can lead to a...

  • Confirming cystic fibrosis. George, Peter // New Zealand Doctor;4/23/2008, p26 

    The article offers clinical information on the diagnosis of cystic fibrosis. In New Zealand, blood spot is collected from the heel of newborn babies to undergo neonatal screening. Such test is used to diagnose cystic fibrosis. In case of first suspicion, the infant is further tested for...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics